CA2135169A1 - Process for stereospecific hydrolysis of piperidinedione derivatives - Google Patents
Process for stereospecific hydrolysis of piperidinedione derivativesInfo
- Publication number
- CA2135169A1 CA2135169A1 CA002135169A CA2135169A CA2135169A1 CA 2135169 A1 CA2135169 A1 CA 2135169A1 CA 002135169 A CA002135169 A CA 002135169A CA 2135169 A CA2135169 A CA 2135169A CA 2135169 A1 CA2135169 A1 CA 2135169A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- process according
- paroxetine
- isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000007062 hydrolysis Effects 0.000 title description 2
- 238000006460 hydrolysis reaction Methods 0.000 title description 2
- 229940053994 hypnotics and sedatives piperidinedione derivative Drugs 0.000 title 1
- 150000005458 piperidinediones Chemical class 0.000 title 1
- 230000000707 stereoselective effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 43
- 108010051152 Carboxylesterase Proteins 0.000 claims abstract description 11
- 102000013392 Carboxylesterase Human genes 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 claims description 13
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 claims description 13
- 229960002296 paroxetine Drugs 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 8
- 108090000371 Esterases Proteins 0.000 claims description 7
- 210000004185 liver Anatomy 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000012453 solvate Substances 0.000 claims description 6
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- -1 carboxy esterone Chemical compound 0.000 claims description 3
- 239000003791 organic solvent mixture Substances 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 2
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- CEXCHYIGFUAPKW-UHFFFAOYSA-N methanol;piperidine Chemical compound OC.C1CCNCC1 CEXCHYIGFUAPKW-UHFFFAOYSA-N 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- QMEZUZOCLYUADC-UHFFFAOYSA-N hydrate;dihydrochloride Chemical compound O.Cl.Cl QMEZUZOCLYUADC-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- CNMOHEDUVVUVPP-UHFFFAOYSA-N piperidine-2,3-dione Chemical compound O=C1CCCNC1=O CNMOHEDUVVUVPP-UHFFFAOYSA-N 0.000 description 1
- KNCYXPMJDCCGSJ-UHFFFAOYSA-N piperidine-2,6-dione Chemical compound O=C1CCCC(=O)N1 KNCYXPMJDCCGSJ-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9209687.4 | 1992-05-06 | ||
| GB929209687A GB9209687D0 (en) | 1992-05-06 | 1992-05-06 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2135169A1 true CA2135169A1 (en) | 1993-11-11 |
Family
ID=10715029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002135169A Abandoned CA2135169A1 (en) | 1992-05-06 | 1993-04-06 | Process for stereospecific hydrolysis of piperidinedione derivatives |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20010018205A1 (en, 2012) |
| EP (1) | EP0639180B1 (en, 2012) |
| JP (1) | JPH07507277A (en, 2012) |
| KR (1) | KR100287082B1 (en, 2012) |
| CN (2) | CN1059898C (en, 2012) |
| AP (1) | AP404A (en, 2012) |
| AT (1) | ATE194329T1 (en, 2012) |
| AU (1) | AU673166B2 (en, 2012) |
| BR (1) | BR9306326A (en, 2012) |
| CA (1) | CA2135169A1 (en, 2012) |
| CZ (1) | CZ283702B6 (en, 2012) |
| DE (1) | DE69328969T2 (en, 2012) |
| DK (1) | DK0639180T3 (en, 2012) |
| ES (1) | ES2147196T3 (en, 2012) |
| FI (1) | FI106855B (en, 2012) |
| GB (1) | GB9209687D0 (en, 2012) |
| GR (1) | GR3034034T3 (en, 2012) |
| HU (1) | HU215411B (en, 2012) |
| IL (1) | IL105162A (en, 2012) |
| MA (1) | MA22848A1 (en, 2012) |
| MX (1) | MX9301754A (en, 2012) |
| MY (1) | MY110188A (en, 2012) |
| NO (1) | NO944215L (en, 2012) |
| NZ (1) | NZ251404A (en, 2012) |
| PL (1) | PL172067B1 (en, 2012) |
| PT (1) | PT639180E (en, 2012) |
| RU (1) | RU2108393C1 (en, 2012) |
| SI (1) | SI9300158A (en, 2012) |
| SK (1) | SK281767B6 (en, 2012) |
| TW (1) | TW258732B (en, 2012) |
| WO (1) | WO1993022284A1 (en, 2012) |
| ZA (1) | ZA932212B (en, 2012) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
| EP0937152A2 (en) * | 1996-07-15 | 1999-08-25 | Smithkline Beecham Plc | Screening for and use of an esterase for a stereospecific resolution |
| GB9618967D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Pharmaceuticals |
| DE29724281U1 (de) | 1997-06-10 | 2000-08-10 | Synthon Bv | 4-Phenylpiperidin-Verbindungen |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| IT1308629B1 (it) | 1999-02-23 | 2002-01-09 | Recordati Chem Pharm | Processo per la produzione di paroxetina. |
| ES2161167B1 (es) * | 1999-09-24 | 2002-07-01 | Vita Invest Sa | Procedimiento de hidrolisis enzimatica de esteres del acido (3sr,4rs)-4-(4-fluorofenil)-6-oxopiperidin-3-carboxilico con biocatalizadores de lipasas o esterasas inmovilizadas. |
| AU2000246280A1 (en) | 2000-05-12 | 2001-11-20 | Synthon B.V. | Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols |
| WO2009005647A2 (en) * | 2007-06-27 | 2009-01-08 | Bioverdant, Inc. | Compounds and process to prepare chiral intermediates for synthesis of paroxetine |
| CN104892491B (zh) * | 2015-05-06 | 2017-05-17 | 浙江海森药业有限公司 | 一种合成帕罗西汀手性中间体的方法 |
| KR102168129B1 (ko) | 2018-11-28 | 2020-10-20 | 장영선 | 넝쿨작물용 줄기 유인용 집게 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3010104A1 (de) * | 1980-03-15 | 1981-10-01 | Basf Ag, 6700 Ludwigshafen | Aminoazoverbindungen |
| DE3680184D1 (de) * | 1985-08-10 | 1991-08-14 | Beecham Group Plc | Verfahren zur herstellung von arylpiperidincarbinol. |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| DK716088D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Reduktion af piperidin-dion-derivater samt intermediat |
| US5258517A (en) * | 1992-08-06 | 1993-11-02 | Sepracor, Inc. | Method of preparing optically pure precursors of paroxetine |
-
1992
- 1992-05-06 GB GB929209687A patent/GB9209687D0/en active Pending
-
1993
- 1993-03-25 IL IL10516293A patent/IL105162A/en not_active IP Right Cessation
- 1993-03-25 AP APAP/P/1993/000501A patent/AP404A/en active
- 1993-03-29 MX MX9301754A patent/MX9301754A/es not_active IP Right Cessation
- 1993-03-29 ZA ZA932212A patent/ZA932212B/xx unknown
- 1993-03-31 MY MYPI93000567A patent/MY110188A/en unknown
- 1993-03-31 SI SI9300158A patent/SI9300158A/sl unknown
- 1993-03-31 MA MA23143A patent/MA22848A1/fr unknown
- 1993-04-01 CN CN93104523A patent/CN1059898C/zh not_active Expired - Fee Related
- 1993-04-06 AT AT93908004T patent/ATE194329T1/de not_active IP Right Cessation
- 1993-04-06 PT PT93908004T patent/PT639180E/pt unknown
- 1993-04-06 DK DK93908004T patent/DK0639180T3/da active
- 1993-04-06 BR BR9306326A patent/BR9306326A/pt not_active Application Discontinuation
- 1993-04-06 ES ES93908004T patent/ES2147196T3/es not_active Expired - Lifetime
- 1993-04-06 AU AU38999/93A patent/AU673166B2/en not_active Ceased
- 1993-04-06 EP EP93908004A patent/EP0639180B1/en not_active Expired - Lifetime
- 1993-04-06 JP JP5519022A patent/JPH07507277A/ja active Pending
- 1993-04-06 CA CA002135169A patent/CA2135169A1/en not_active Abandoned
- 1993-04-06 RU RU94046012A patent/RU2108393C1/ru active
- 1993-04-06 HU HU9403189A patent/HU215411B/hu not_active IP Right Cessation
- 1993-04-06 NZ NZ251404A patent/NZ251404A/en unknown
- 1993-04-06 SK SK1315-94A patent/SK281767B6/sk unknown
- 1993-04-06 DE DE69328969T patent/DE69328969T2/de not_active Expired - Fee Related
- 1993-04-06 CZ CZ942712A patent/CZ283702B6/cs not_active IP Right Cessation
- 1993-04-06 PL PL93305801A patent/PL172067B1/pl unknown
- 1993-04-06 WO PCT/GB1993/000721 patent/WO1993022284A1/en active IP Right Grant
- 1993-04-14 TW TW082102827A patent/TW258732B/zh active
-
1994
- 1994-11-04 FI FI945209A patent/FI106855B/fi active
- 1994-11-04 NO NO944215A patent/NO944215L/no not_active Application Discontinuation
- 1994-11-05 KR KR1019940703956A patent/KR100287082B1/ko not_active Expired - Fee Related
-
2000
- 2000-04-03 CN CN00104973A patent/CN1291653A/zh active Pending
- 2000-07-27 GR GR20000401724T patent/GR3034034T3/el not_active IP Right Cessation
-
2001
- 2001-03-21 US US09/813,755 patent/US20010018205A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2135169A1 (en) | Process for stereospecific hydrolysis of piperidinedione derivatives | |
| PL148128B1 (en) | Method of separating racemates of 2-halogenopropionic acids to obtain optic isomers therefrom | |
| US4338251A (en) | Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same | |
| RU1816287C (ru) | Способ получени S(+) анантиомера 2-арилалкановой кислоты | |
| US4625040A (en) | N-(phenyl) or N-(phenylcyclopropyl)-2,5-dihydro-2-oxo-4[(substituted phenyl)amino]-3-furancarboxamide derivatives | |
| CZ301944B6 (cs) | Zpusob enzymatického delení enantiomeru 3[R]- a 3[S]-hydroxy-1-methyl-4-[2,4,6-trimethoxyfenyl]-1,2,3,6-tetrahydropyridinu, poprípade esteru karboxylových kyselin | |
| US6184004B1 (en) | Process for the preparation of galanthamine and its derivatives | |
| SK143793A3 (en) | The enzymatic process for the stereoselective preparation of a heterobicyclic alcohol enantiomer | |
| NZ333445A (en) | Process for obtaining enantiomerically enriched N-acylazetidine-2-carboxylic acids comprising the biotransformation of racemic N-acylazetidine-2-carboxylic acid ester with an enantiospecific enzyme | |
| IE882938L (en) | Phosphinic acid derivatives | |
| DE69721812T2 (de) | Verfahren zur herstellung optisch aktiver 3-quinuclidinol derivate | |
| WO2006015716A2 (de) | Verfahren zur herstellung der enantiomeren formen von cis-konfigurierten 3-hydroxycyclohexancarbonsäure-derivaten unter verwendung von hydrolasen | |
| US4468458A (en) | Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same | |
| CZ20011465A3 (cs) | Způsob přípravy 4-arylpiperidin-3-methanolů a příbuzných sloučenin | |
| US5175297A (en) | Methyl-quinoline derivatives as mefloquin intermediates and process for preparation thereof | |
| HK1012374B (en) | Process for stereospecific hydrolysis of piperidinedione derivatives | |
| US5280122A (en) | Resolution of 2-benzyl-4-piperidone-succinic acid | |
| DE69525433T2 (de) | Intermediate für die Synthese von Eliprodilenantiomeren und Verfahren zu ihrer Herstellung | |
| US2945046A (en) | Process for preparing 5 hydroxy-tryptamine through new intermediates | |
| JPH07184685A (ja) | 光学的に純粋なテトラヒドロキノリン誘導体の合成法 | |
| US20040110796A1 (en) | Alkyl esters of 3- (3,4-dihalophenyl) -2, 6 -di -oxopiperidine-3 -propionic acid of use as intermediates | |
| WO2001018231A2 (de) | VERFAHREN ZUR HERSTELLUNG VON (R)- ODER (S)-HYDROXY-η-BUTYROLACTON | |
| JPH0322992A (ja) | 微生物を利用した光学活性ベンゾヒドロール誘導体の製造法 | |
| DE3733506A1 (de) | Verfahren zur herstellung optisch reiner phenylringsubstituierter phenylalaninderivate | |
| EP0387605A2 (de) | Verfahren zur stereoselektiven Herstellung von optisch aktiven S,S- oder R,R-beta-Aminoalkoholen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |